FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to psychiatry and immunology, and can be used for therapy of patients with mixed anxiety and depressive disorder, which are carriers of antibodies to herpes viruses. Antidepressant Fluvoxamine 50 mg is prescribed daily at bedtime for 28 days. In addition, the preparation Ethylmethylhydroxypyridine succinate is prescribed orally in dosage of 150 mg 3 times a day in a tablet, the therapeutic course is 14 days.
EFFECT: invention provides improved mental status of patients, in particular reduced frequency of anxiety, discomfort, tearfulness, aggression, pessimism, manifestations of somatic symptoms, internal tension, asthenia, memory disorders, improved mood, sleep quality.
1 cl, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATMENT OF DUODENUM ULCER DISEASE COMPLICATED BY COMORBID ANXIOUS DEPRESSION DISORDERS | 2007 |
|
RU2357729C2 |
| ANTIDEPRESSIVE THERAPY | 2008 |
|
RU2379035C1 |
| METHOD FOR ASSESSING SEVERITY OF A CURRENT DEPRESSIVE EPISODE IN COMORBIDITY OF AFFECTIVE AND PERSONALITY DISORDERS | 2015 |
|
RU2599975C1 |
| METHOD FOR OBJECTIFYING INDICATIONS FOR PRESCRIBING LAMOTRIGINE IN TREATING DEPRESSION | 2023 |
|
RU2824036C1 |
| METHOD FOR PREDICTING CLINICAL BEHAVIOR OF CARDIAC ISCHEMIA DISEASE | 2001 |
|
RU2228534C2 |
| METHOD OF TREATING PATIENTS WITH BORDERLINE NEUROPSYCHIC PATHOLOGY | 2019 |
|
RU2691512C1 |
| METHOD AND AGENT FOR TREATMENT OF DEPRESSION DURING PREGNANCY AT WOMEN WITH SYNDROME OF LOSS OF FETUS IN ANAMNESIS | 2007 |
|
RU2350328C1 |
| 3,6,9-TRIAZATRICYCLOTETRADECANE DERIVATIVE AND USE THEREOF FOR TREATING DEPRESSION | 2019 |
|
RU2700595C1 |
| METHOD FOR TREATING ALOPECIAS WITH CONCOMITANT PSYCHOSOMATIC DISORDERS | 2020 |
|
RU2756002C1 |
| METHOD FOR PREDICTION OF COURSE OF ADAPTATION DISORDER | 2019 |
|
RU2717307C1 |
